Merck Sued For Securities Fraud Over Cholesterol Drug Trial

Law360, Los Angeles (December 4, 2013, 4:38 PM EST) -- North Sound Capital LLC and two other institutional funds have sued Merck & Co. Inc. and its subsidiary for allegedly misrepresenting a crucial clinical study for its anti-cholesterol agents Zetia and Vytorin, according to court documents made public in New Jersey federal court on Wednesday.

North Sound, United Food Commercial Workers Local 1500 Pension Fund and Colonial First State Investments Ltd. accuse the defendants of common law fraud and of violating of the Securities Exchange Act of 1934 for concealing material and making false statements that...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

NORTH SOUND CAPITAL LLC et al v. MERCK & CO., INC. et al


Case Number

3:13-cv-07240

Court

New Jersey

Nature of Suit

Securities/Commodities

Judge

Freda L. Wolfson

Date Filed

November 14, 2013

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.